Luteal phase defects following agonist-triggered ovulation: a patient-dependent response-Reference-Cited by-同舟云学术

Luteal phase defects following agonist-triggered ovulation: a patient-dependent response

Published:2004-01 Issue:1 Volume:9 Page:22-27
ISSN:1472-6483
Container-title:Reproductive BioMedicine Online
language:en
Short-container-title:Reproductive BioMedicine Online

Author:

Emperaire JC,Parneix I,Ruffie A

Publisher

Elsevier BV

Subject

Developmental Biology,Reproductive Medicine,Obstetrics and Gynecology

Reference41 articles.

1. Further characterization of the luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles;Balasch;Human Reproduction,1995

2. Triggering the final stage of ovulation using gonadotrophin-releasing hormone analogues: effective dose, prevention of ovarian hyperstimulation syndrome and the luteal phase;Ben Arie;Human Reproduction,1996

3. Effects of varying doses of u-HCG on the evolution of preovulatory rabbit follicles and oocytes;Bomsel-Helmreich;Human Reproduction,1989

4. Does triggering ovulation with gonadotrophin-releasing hormone analogue prevent severe ovarian hyperstimulation syndrome?;Casper;Human Reproduction,1996

5. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles II: progesterone receptor expression in luteinizing granulosa cells;Chandrasekher;Journal of Clinical Endocrinology and Metabolism,1991

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triggering of ovulation for GnRH-antagonist cycles in normal and low ovarian responders undergoing IVF/ICSI: A systematic review and meta-analysis of randomized trials;European Journal of Obstetrics & Gynecology and Reproductive Biology;2023-10

2. Luteal Phase in Assisted Reproductive Technology;Frontiers in Reproductive Health;2020-12-07

3. Gonadotropin-releasing hormone agonist for ovulation trigger – OHSS prevention and use of modified luteal phase support for fresh embryo transfer;Upsala Journal of Medical Sciences;2020-04-02

4. Is oocyte maturation rate associated with triptorelin dose used for triggering final oocyte maturation in patients at high risk for severe ovarian hyperstimulation syndrome?;Human Reproduction;2019-08-06

5. Gonadotropin-Releasing Hormone Agonist Versus Human Chorionic Gonadotropin for Ovulation Induction in Polycystic Ovary Syndrome Patients Undergoing Intrauterine Insemination: A Randomised Controlled Trial;Fertility & Reproduction;2019-06